Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
57
XOM Quote, Financials, Valuation and Earnings
Last price:
$148.46
Seasonality move
:
2.81%
Day range:
$147.98 - $151.66
52-week range:
$97.80 - $156.93
Dividend yield:
2.72%
P/E ratio:
22.19x
P/S ratio:
1.98x
P/B ratio:
2.39x
Volume:
20.2M
Avg. volume:
21.5M
1-year change:
37.29%
Market cap:
$620.4B
Revenue:
$323.9B
EPS (TTM):
$6.69
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $280.5B | $400.4B | $333.7B | $339.9B | $323.9B | |
| Revenue Growth (YoY) | 57.44% | 42.75% | -16.66% | 1.86% | -4.71% | |
| Cost of Revenues | $212.9B | $296.9B | $251.4B | $263.3B | $253.7B | |
| Gross Profit | $67.6B | $103.5B | $82.3B | $76.6B | $70.2B | |
| Gross Profit Margin | 24.1% | 25.85% | 24.67% | 22.53% | 21.68% | |
| R&D Expenses | $843M | $824M | $879M | $987M | -- | |
| Selling, General & Admin | $9.6B | $10.1B | $9.9B | $10B | $11.1B | |
| Other Inc / (Exp) | $8.2B | $14.5B | $9.2B | $10.2B | -- | |
| Operating Expenses | $39.8B | $38B | $38.9B | $36.3B | $36.3B | |
| Operating Income | $27.8B | $65.5B | $43.4B | $40.3B | $33.9B | |
| Net Interest Expenses | $947M | $798M | $849M | $996M | $603M | |
| EBT. Incl. Unusual Items | $31.2B | $77.8B | $52.8B | $48.9B | $41.3B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $7.6B | $20.2B | $15.4B | $13.8B | $11.5B | |
| Net Income to Company | $23.6B | $57.6B | $37.4B | $35.1B | $29.8B | |
| Minority Interest in Earnings | $558M | $1.8B | $1.3B | $1.4B | $920M | |
| Net Income to Common Excl Extra Items | $23.6B | $57.6B | $37.4B | $35.1B | $29.8B | |
| Basic EPS (Cont. Ops) | $5.39 | $13.26 | $8.89 | $7.84 | $6.70 | |
| Diluted EPS (Cont. Ops) | $5.39 | $13.26 | $8.89 | $7.84 | $6.70 | |
| Weighted Average Basic Share | $4.3B | $4.2B | $4.1B | $4.3B | -- | |
| Weighted Average Diluted Share | $4.3B | $4.2B | $4.1B | $4.3B | $4.3B | |
| EBITDA | $48.4B | $89.5B | $64B | $63.8B | $59.9B | |
| EBIT | $27.8B | $65.5B | $43.4B | $40.3B | $33.9B | |
| Revenue (Reported) | $280.5B | $400.4B | $333.7B | $339.9B | $323.9B | |
| Operating Income (Reported) | $27.8B | $65.5B | $43.4B | $40.3B | $33.9B | |
| Operating Income (Adjusted) | $27.8B | $65.5B | $43.4B | $40.3B | $33.9B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $81.9B | $91.9B | $80.6B | $81.5B | $80B | |
| Revenue Growth (YoY) | 78.02% | 12.2% | -12.28% | 1.09% | -1.81% | |
| Cost of Revenues | $62.6B | $66.9B | $64.2B | $64B | $64.6B | |
| Gross Profit | $19.4B | $25B | $16.4B | $17.5B | $15.4B | |
| Gross Profit Margin | 23.64% | 27.19% | 20.4% | 21.48% | 19.28% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.5B | $2.8B | $2.6B | $2.6B | $3B | |
| Other Inc / (Exp) | $3.6B | $2.2B | $2.4B | $2.3B | -- | |
| Operating Expenses | $10.5B | $9.7B | $9.1B | $9.3B | $9.4B | |
| Operating Income | $8.9B | $15.2B | $7.3B | $8.2B | $6B | |
| Net Interest Expenses | $221M | $207M | $272M | $297M | $163M | |
| EBT. Incl. Unusual Items | $11.7B | $18.8B | $10.6B | $9.8B | $8B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.7B | $5.8B | $2.6B | $1.9B | $1.4B | |
| Net Income to Company | $9.1B | $13.1B | $8B | $8B | $6.6B | |
| Minority Interest in Earnings | $209M | $305M | $382M | $345M | $108M | |
| Net Income to Common Excl Extra Items | $9.1B | $13.1B | $8B | $8B | $6.6B | |
| Basic EPS (Cont. Ops) | $2.07 | $3.12 | $1.92 | $1.75 | $1.53 | |
| Diluted EPS (Cont. Ops) | $2.07 | $3.08 | $1.90 | $1.72 | $1.53 | |
| Weighted Average Basic Share | $4.3B | $4.1B | $4B | $4.4B | -- | |
| Weighted Average Diluted Share | $4.3B | $4.1B | $4B | $4.4B | $4.2B | |
| EBITDA | $14.6B | $20.3B | $15.1B | $14.8B | $13.7B | |
| EBIT | $8.9B | $15.2B | $7.3B | $8.2B | $6B | |
| Revenue (Reported) | $81.9B | $91.9B | $80.6B | $81.5B | $80B | |
| Operating Income (Reported) | $8.9B | $15.2B | $7.3B | $8.2B | $6B | |
| Operating Income (Adjusted) | $8.9B | $15.2B | $7.3B | $8.2B | $6B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $280.5B | $400.4B | $333.7B | $339.9B | $323.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $212.9B | $296.9B | $251.4B | $263.3B | $253.7B | |
| Gross Profit | $67.6B | $103.5B | $82.3B | $76.6B | $69.7B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $9.6B | $10.1B | $9.9B | $10B | $11.1B | |
| Other Inc / (Exp) | $8.2B | $14.5B | $9.2B | $10.2B | -- | |
| Operating Expenses | $39.8B | $38B | $38.9B | $36.3B | $36.3B | |
| Operating Income | $27.8B | $65.5B | $43.4B | $40.3B | $33.4B | |
| Net Interest Expenses | $947M | $798M | $849M | $996M | $603M | |
| EBT. Incl. Unusual Items | $31.2B | $77.8B | $52.8B | $48.9B | $41.3B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $7.6B | $20.2B | $15.4B | $13.8B | $11.5B | |
| Net Income to Company | $23.6B | $57.6B | $37.4B | $35.1B | $29.8B | |
| Minority Interest in Earnings | $558M | $1.8B | $1.3B | $1.4B | $920M | |
| Net Income to Common Excl Extra Items | $23.6B | $57.6B | $37.4B | $35.1B | $29.8B | |
| Basic EPS (Cont. Ops) | $5.39 | $13.32 | $8.90 | $7.87 | $6.69 | |
| Diluted EPS (Cont. Ops) | $5.39 | $13.28 | $8.88 | $7.85 | $6.69 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $48.4B | $89.5B | $64B | $63.8B | $59.4B | |
| EBIT | $27.8B | $65.5B | $43.4B | $40.3B | $33.4B | |
| Revenue (Reported) | $280.5B | $400.4B | $333.7B | $339.9B | $323.4B | |
| Operating Income (Reported) | $27.8B | $65.5B | $43.4B | $40.3B | $33.4B | |
| Operating Income (Adjusted) | $27.8B | $65.5B | $43.4B | $40.3B | $33.4B | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $400.4B | $333.7B | $339.9B | $323.4B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $296.9B | $251.4B | $263.3B | $253.7B | -- | |
| Gross Profit | $103.5B | $82.3B | $76.6B | $69.7B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $10.1B | $9.9B | $10B | $11.1B | -- | |
| Other Inc / (Exp) | $14.5B | $9.2B | $10.2B | $2B | -- | |
| Operating Expenses | $38B | $38.9B | $36.3B | $36.3B | -- | |
| Operating Income | $65.5B | $43.4B | $40.3B | $33.4B | -- | |
| Net Interest Expenses | $798M | $849M | $996M | $603M | -- | |
| EBT. Incl. Unusual Items | $77.8B | $52.8B | $48.9B | $41.3B | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $20.2B | $15.4B | $13.8B | $11.5B | -- | |
| Net Income to Company | $57.6B | $37.4B | $35.1B | $29.8B | -- | |
| Minority Interest in Earnings | $1.8B | $1.3B | $1.4B | $920M | -- | |
| Net Income to Common Excl Extra Items | $57.6B | $37.4B | $35.1B | $29.8B | -- | |
| Basic EPS (Cont. Ops) | $13.32 | $8.90 | $7.87 | $6.69 | -- | |
| Diluted EPS (Cont. Ops) | $13.28 | $8.88 | $7.85 | $6.69 | -- | |
| Weighted Average Basic Share | $16.8B | $16.2B | $17.1B | $13B | -- | |
| Weighted Average Diluted Share | $16.8B | $16.2B | $17.2B | $17.2B | -- | |
| EBITDA | $89.5B | $64B | $63.8B | $59.4B | -- | |
| EBIT | $65.5B | $43.4B | $40.3B | $33.4B | -- | |
| Revenue (Reported) | $400.4B | $333.7B | $339.9B | $323.4B | -- | |
| Operating Income (Reported) | $65.5B | $43.4B | $40.3B | $33.4B | -- | |
| Operating Income (Adjusted) | $65.5B | $43.4B | $40.3B | $33.4B | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $6.8B | $29.7B | $31.6B | $23.2B | $10.7B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $26.9B | $32.8B | $30.3B | $35.3B | $44.6B | |
| Inventory | $18.8B | $24.4B | $25.1B | $23.5B | $26.3B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $1.2B | $1.8B | $1.9B | $1.6B | -- | |
| Total Current Assets | $59.2B | $97.6B | $96.6B | $92B | $83.4B | |
| Property Plant And Equipment | $216.6B | $204.7B | $214.9B | $301.4B | $299.4B | |
| Long-Term Investments | $45.2B | $49.8B | $47.6B | $47.2B | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $18B | $17B | $17.1B | $20B | -- | |
| Total Assets | $338.9B | $369.1B | $376.3B | $453.5B | $449B | |
| Accounts Payable | $26.6B | $33.2B | $31.2B | $36.1B | $60.9B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $2.4B | $181M | $4B | $4.9B | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $56.6B | $69B | $65.3B | $70.3B | $72.3B | |
| Long-Term Debt | $47.4B | $44.8B | $42B | $41.5B | $34.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $163.2B | $166.6B | $163.8B | $182.9B | $182.4B | |
| Common Stock | $15.7B | $15.8B | $17.8B | $46.2B | $46.2B | |
| Other Common Equity Adj | -$13.8B | -$13.3B | -$12B | -$14.6B | -- | |
| Common Equity | $168.6B | $195B | $204.8B | $263.7B | $259.4B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $7.1B | $7.4B | $7.7B | $6.9B | $7.2B | |
| Total Equity | $175.7B | $202.5B | $212.5B | $270.6B | $266.6B | |
| Total Liabilities and Equity | $338.9B | $369.1B | $376.3B | $453.5B | $449B | |
| Cash and Short Terms | $6.8B | $29.7B | $31.6B | $23.2B | $10.7B | |
| Total Debt | $49.8B | $44.9B | $46B | $46.4B | $34.2B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $6.8B | $29.7B | $31.6B | $23.2B | $10.7B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $26.9B | $32.8B | $30.3B | $35.3B | $44.6B | |
| Inventory | $18.8B | $24.4B | $25.1B | $23.5B | $26.3B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $1.2B | $1.8B | $1.9B | $1.6B | -- | |
| Total Current Assets | $59.2B | $97.6B | $96.6B | $92B | $83.4B | |
| Property Plant And Equipment | $216.6B | $204.7B | $214.9B | $301.4B | $299.4B | |
| Long-Term Investments | $45.2B | $49.8B | $47.6B | $47.2B | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $18B | $17B | $17.1B | $20B | -- | |
| Total Assets | $338.9B | $369.1B | $376.3B | $453.5B | $449B | |
| Accounts Payable | $49.4B | $33.2B | $31.2B | $36.1B | $60.9B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $2.4B | $181M | $4B | $4.9B | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $56.6B | $69B | $65.3B | $70.3B | $72.3B | |
| Long-Term Debt | $47.4B | $44.8B | $42B | $41.5B | $34.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $163.2B | $166.6B | $163.8B | $182.9B | $182.4B | |
| Common Stock | $15.7B | $15.8B | $17.8B | $46.2B | $46.2B | |
| Other Common Equity Adj | -$13.8B | -$13.3B | -$12B | -$14.6B | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $7.1B | $7.4B | $7.7B | $6.9B | $7.2B | |
| Total Equity | $175.7B | $202.5B | $212.5B | $270.6B | $266.6B | |
| Total Liabilities and Equity | $338.9B | $369.1B | $376.3B | $453.5B | $449B | |
| Cash and Short Terms | $6.8B | $29.7B | $31.6B | $23.2B | $10.7B | |
| Total Debt | $49.8B | $44.9B | $46B | $46.4B | $34.2B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $23.6B | $57.6B | $37.4B | $35.1B | $29.8B | |
| Depreciation & Amoritzation | $20.6B | $24B | $20.6B | $23.4B | $26B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$12.1B | -$11B | $4.4B | -$6B | -- | |
| Change in Inventories | -$489M | -$6.9B | -$3.5B | -$1.8B | -- | |
| Cash From Operations | $48.1B | $76.8B | $55.4B | $55B | $52B | |
| Capital Expenditures | $12.1B | $18.4B | $21.9B | $24.3B | $28.4B | |
| Cash Acquisitions | $436M | $1.5B | $770M | $791M | $704M | |
| Cash From Investing | -$10.7B | -$16.2B | -$20B | -$20.7B | -$26.5B | |
| Dividends Paid (Ex Special Dividend) | $14.9B | $14.9B | $14.9B | $16.7B | $17.2B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $12.7B | $860M | $939M | $899M | -- | |
| Long-Term Debt Repaid | -$32.4B | -$8.1B | -$1.2B | -$5.9B | -- | |
| Repurchase of Common Stock | $155M | $15.2B | $17.7B | $19.6B | $20.3B | |
| Other Financing Activities | -$690M | -$1.8B | -$1.4B | -$1.4B | -- | |
| Cash From Financing | -$35B | -$37.6B | -$33.5B | -$42B | -$38.5B | |
| Beginning Cash (CF) | $6.8B | $29.7B | $31.6B | $23.2B | $10.7B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.4B | $22.9B | $1.9B | -$8.4B | -$12.5B | |
| Ending Cash (CF) | $9.2B | $52.5B | $33.6B | $14.1B | -$1.3B | |
| Levered Free Cash Flow | $36.1B | $58.4B | $33.5B | $30.7B | $23.6B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $9.1B | $13.1B | $8B | $8B | $6.6B | |
| Depreciation & Amoritzation | $5.7B | $5.1B | $7.7B | $6.6B | $7.7B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $17.1B | $17.6B | $13.7B | $12.2B | $12.7B | |
| Capital Expenditures | $4.1B | $5.8B | $6.2B | $6.8B | $7.5B | |
| Cash Acquisitions | $158M | $401M | $512M | $490M | $364M | |
| Cash From Investing | -$2.3B | -$5.8B | -$6.2B | -$4.7B | -$7.4B | |
| Dividends Paid (Ex Special Dividend) | $3.8B | $3.8B | $3.8B | $4.4B | $4.4B | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -$507M | -$833M | $134M | $473M | -- | |
| Long-Term Debt Repaid | -$8.3B | -$4.2B | -$662M | -$929M | -- | |
| Repurchase of Common Stock | $154M | $4.7B | $4.7B | $5.8B | $5.4B | |
| Other Financing Activities | -$218M | -$477M | -$532M | -$536M | -- | |
| Cash From Financing | -$12.8B | -$13.5B | -$9B | -$10.7B | -$8.5B | |
| Beginning Cash (CF) | $6.8B | $29.7B | $31.6B | $23.2B | $10.7B | |
| Foreign Exchange Rate Adjustment | -$21M | $872M | $182M | -$619M | -- | |
| Additions / Reductions | $2B | -$799M | -$1.4B | -$3.8B | -$3.2B | |
| Ending Cash (CF) | $8.8B | $29.7B | $30.3B | $18.8B | $7.5B | |
| Levered Free Cash Flow | $13B | $11.8B | $7.5B | $5.4B | $5.2B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $23.6B | $57.6B | $37.4B | $35.1B | $29.8B | |
| Depreciation & Amoritzation | $20.6B | $24B | $20.6B | $23.4B | $26B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $48.1B | $76.8B | $55.4B | $55B | $52B | |
| Capital Expenditures | $12.1B | $18.4B | $21.9B | $24.3B | $28.4B | |
| Cash Acquisitions | $436M | $1.5B | $770M | $791M | $704M | |
| Cash From Investing | -$10.7B | -$16.2B | -$20B | -$20.7B | -$26.5B | |
| Dividends Paid (Ex Special Dividend) | $14.9B | $14.9B | $14.9B | $16.7B | $17.2B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $12.7B | $860M | $939M | $899M | -- | |
| Long-Term Debt Repaid | -$32.4B | -$8.1B | -$1.2B | -$5.9B | -- | |
| Repurchase of Common Stock | $155M | $15.2B | $17.7B | $19.6B | $20.3B | |
| Other Financing Activities | -$690M | -$1.8B | -$1.4B | -$1.4B | -- | |
| Cash From Financing | -$35B | -$37.6B | -$33.5B | -$42B | -$38.5B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.4B | $22.9B | $1.9B | -$8.4B | -$12.5B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $36.1B | $58.4B | $33.5B | $30.7B | $23.6B | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $57.6B | $37.4B | $35.1B | $29.8B | -- | |
| Depreciation & Amoritzation | $24B | $20.6B | $23.4B | $26B | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $76.8B | $55.4B | $55B | $52B | -- | |
| Capital Expenditures | $18.4B | $21.9B | $24.3B | $28.4B | -- | |
| Cash Acquisitions | $1.5B | $770M | $791M | $704M | -- | |
| Cash From Investing | -$16.2B | -$20B | -$20.7B | -$26.5B | -- | |
| Dividends Paid (Ex Special Dividend) | $14.9B | $14.9B | $16.7B | $17.2B | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $860M | $939M | $899M | $280M | -- | |
| Long-Term Debt Repaid | -$8.1B | -$1.2B | -$5.9B | -$4.6B | -- | |
| Repurchase of Common Stock | $15.2B | $17.7B | $19.6B | $20.3B | -- | |
| Other Financing Activities | -$1.8B | -$1.4B | -$1.4B | -$131M | -- | |
| Cash From Financing | -$37.6B | -$33.5B | -$42B | -$38.5B | -- | |
| Beginning Cash (CF) | $90.1B | $126.8B | $110B | $58.8B | -- | |
| Foreign Exchange Rate Adjustment | -$78M | $105M | -$676M | $532M | -- | |
| Additions / Reductions | $22.9B | $1.9B | -$8.4B | -$12.5B | -- | |
| Ending Cash (CF) | $112.8B | $128.8B | $100.9B | $46.8B | -- | |
| Levered Free Cash Flow | $58.4B | $33.5B | $30.7B | $23.6B | -- | |
Get XOM Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
XOM
Sector
P/E ratio
22.19x
13.90x
PEG ratio
--
0.00x
P/B ratio
2.39x
1.06x
Price / LTM sales
1.98x
1.04x
Growth Metrics
XOM
Sector
Revenue growth
-1.81%
-3.74%
Earnings growth
-11.27%
-16.24%
Revenue (5-year growth)
12.7%
5.85%
Earnings forecast
$1.69
$0.17
Profitability
XOM
Sector
Profitability FY 2025
$70.2B
$11.8M
Return on invested capital
9.57%
1.78%
Return on assets
6.6%
0.34%
Return on equity
11.06%
3.18%
Earnings Date
Last Earnings Date
Jan
30
Next Earnings Date
May
1
Estimated Next Earnings Date
May
1
Balance Sheet
XOM
Sector
Total cash
$10.7B
$9.8M
Short term investments
--
$2.2M
Total assets
$449B
$268.8M
Long term debt
$34.2B
$11.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
77
CPS alert for Feb 14
Cooper-Standard Holdings, Inc. [CPS] is up 32.06% over the past day.
Buy
58
TPH alert for Feb 14
Tri Pointe Homes, Inc. [TPH] is up 26.83% over the past day.
Sell
20
IRON alert for Feb 14
Disc Medicine, Inc. [IRON] is down 21.88% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
